Targeting Melanin Production: The Safety of Tyrosinase Inhibition
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010097 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Steffen Erler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Beiersdorf AG, 20245 Hamburg, Germany. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Melanins, Enzyme Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beiersdorf AG, Hamburg, Germany.
Abstract (Originalsprache)
Hyperpigmentation remains a persistent dermatological challenge with limited treatment options. Among available strategies, tyrosinase inhibition stands out as the current most effective and safest approach for suppressing melanin synthesis. Thiamidol exemplifies a targeted tyrosinase inhibitor developed over a decade of research, guided by rigorous toxicological evaluation. Although it contains a resorcinol moiety, Thiamidol is not a resorcinol derivative and acts through a distinct thiazole 2-amino moiety. In addition to its targeted mode of action of tyrosinase inhibition rather than inactivation, assessments of cytotoxicity and genotoxicity distinguish it from cosmetic and pharmaceutical active ingredients that form highly reactive ortho- or para-quinones. With further exclusion for off-target effects based on pharma profiling and exposure modeling, Thiamidol’s rapid metabolism and absence of bioaccumulation support its safety profile. While an inhibitory mechanism requires repeated application, this characteristic enhances the safety profile and establishes Thiamidol as a cosmetic ingredient rather than a pharmaceutical. In additional to confirmatory clinical studies for efficacy and skin compatibility, a study shows that the use of Thiamidol-containing products does not negatively impact the dermatological diagnostic accessibility of naevi, which is important for skin health monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development, Beiersdorf AG, 20245 Hamburg, Germany.
ORCID-Profile: Ludger Kolbe, Andreas Schepky, Ahmed Kamal, Tamara Rogers
Förderung
- Beiersdorf AG, Hamburg, Germany
Zitieren
APA
Erler, S., Kolbe, L., Najjar, A., Schepky, A., Kamal, A., Lange, D., & Rogers, T. (2025). Targeting Melanin Production: The Safety of Tyrosinase Inhibition. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010097
Vancouver
Erler S, Kolbe L, Najjar A, Schepky A, Kamal A, Lange D, et al. Targeting Melanin Production: The Safety of Tyrosinase Inhibition. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010097
BibTeX
@article{Erler2025,
author = {Erler, Steffen and Kolbe, Ludger and Najjar, Abdulkarim and Schepky, Andreas and Kamal, Ahmed and Lange, Daniela and Rogers, Tamara},
title = {Targeting Melanin Production: The Safety of Tyrosinase Inhibition},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010097}
}
EUVIMED